In a significant stride towards advancing the future of immunotherapy, Gritstone Bio has successfully raised an impressive $433 million in its latest funding round. Founded by a collective of distinguished scientists and industry veterans, Gritstone Bio is at the forefront of developing next-generation vaccines focused on both cancer and infectious diseases. Their innovative approach centers on exploiting the immune system's remarkable ability to identify and eliminate diseased cells by targeting specific antigens, with a strong emphasis on tumor-specific neoantigens. With this newfound capital, the company aims to expand its research and development efforts, accelerating the advancement of its pioneering treatments that leverage both anti-tumor and anti-viral immunity. Recent initiatives include the exploration of viral antigens present on the surfaces of virus-infected cells, further demonstrating Gritstone鈥檚 commitment to not only combating cancer but also addressing pressing global health challenges posed by infectious diseases. The strategic deployment of these funds will enhance Gritstone's clinical trials while also fostering collaborations that can amplify their innovative solutions in immuno-oncology. With their seasoned leadership team and accomplished board of directors steering the ship, Gritstone Bio is poised to make meaningful impacts in the fields of oncology and infectious disease, ultimately offering hope and improved therapeutic outcomes for patients worldwide. This funding marks an exciting chapter for Gritstone Bio as they accelerate their mission to harness the power of the immune system for transformative treatments.
Revolutionizing Immunotherapy: Gritstone Bio Secures $433M in Funding for Next-Generation Vaccines
Recently funded 路 $433.0MBiotechnology
Get the full Gritstone Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
